{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:07:47Z","timestamp":1778803667325,"version":"3.51.4"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,14]]},"DOI":"10.7759\/cureus.108859","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:14:17Z","timestamp":1778800457000},"source":"Crossref","is-referenced-by-count":0,"title":["Atopic Dermatitis During Ustekinumab Therapy in a Patient With Ulcerative Colitis: A Case Report and Review of Targeted Therapies in Coexisting Diseases"],"prefix":"10.7759","author":[{"given":"Aya","family":"Maeyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunari","family":"Sugita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.5MR0120-230R","article-title":"Tight junctions in the development of asthma, chronic rhinosinusitis, atopic dermatitis, eosinophilic esophagitis, and inflammatory bowel diseases","volume":"108","author":"Sugita K","year":"2020","unstructured":"Sugita K, Kabashima K. Tight junctions in the development of asthma, chronic rhinosinusitis, atopic dermatitis, eosinophilic esophagitis, and inflammatory bowel diseases. J Leukoc Biol. 2020, 108:749-62. 10.1002\/JLB.5MR0120-230R","journal-title":"J Leukoc Biol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15237","article-title":"Patient with atopic dermatitis, hyper IgE syndrome and ulcerative colitis, treated successfully with dupilumab during pregnancy","volume":"35","author":"Gracia-Darder I","year":"2022","unstructured":"Gracia-Darder I, Pons De Ves J, Reyero Cortina M, Mart\u00edn-Santiago A. Patient with atopic dermatitis, hyper IgE syndrome and ulcerative colitis, treated successfully with dupilumab during pregnancy. Dermatol Ther. 2022, 35:e15237. 10.1111\/dth.15237","journal-title":"Dermatol Ther"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16928","article-title":"Ulcerative colitis during dupilumab therapy in a patient with atopic dermatitis","volume":"50","author":"Seishima M","year":"2023","unstructured":"Seishima M, Sasaki M, Hachiken H, Furukawa T, Yagi N, Sugie S. Ulcerative colitis during dupilumab therapy in a patient with atopic dermatitis. J Dermatol. 2023, 50:420-1. 10.1111\/1346-8138.16928","journal-title":"J Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59030542","article-title":"Atopic dermatitis and ulcerative colitis successfully treated with upadacitinib","volume":"59","author":"Grieco T","year":"2023","unstructured":"Grieco T, Caviglia M, Cusano G, et al.. Atopic dermatitis and ulcerative colitis successfully treated with upadacitinib. Medicina (Kaunas). 2023, 59:542. 10.3390\/medicina59030542","journal-title":"Medicina (Kaunas)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.23736\/S2784-8671.24.07957-X","article-title":"The potential of upadacitinib in treating co-occurring atopic dermatitis and ulcerative colitis","volume":"159","author":"Lasagni G","year":"2024","unstructured":"Lasagni G, Tavoletti G, Maronese CA, Chiei Gallo A, Marzano AV, Ferrucci SM. The potential of upadacitinib in treating co-occurring atopic dermatitis and ulcerative colitis. Ital J Dermatol Venerol. 2024, 159:697-8. 10.23736\/S2784-8671.24.07957-X","journal-title":"Ital J Dermatol Venerol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izaa243","article-title":"Tofacitinib for the treatment of ulcerative colitis, alopecia universalis, and atopic dermatitis: one drug, three diseases","volume":"27","author":"Honap S","year":"2021","unstructured":"Honap S, Cookson H, Sharma E, Samaan MA, Irving PM. Tofacitinib for the treatment of ulcerative colitis, alopecia universalis, and atopic dermatitis: one drug, three diseases. Inflamm Bowel Dis. 2021, 27:e13-4. 10.1093\/ibd\/izaa243","journal-title":"Inflamm Bowel Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1429009","article-title":"Histamine and Th2 cytokines independently and synergistically upregulate MMP12 expression in human M2 macrophages","volume":"15","author":"Pereira da Fonseca A","year":"2024","unstructured":"Pereira da Fonseca A, Traidl S, Gutzmer R, Schaper-Gerhardt K, Werfel T, Mommert S. Histamine and Th2 cytokines independently and synergistically upregulate MMP12 expression in human M2 macrophages. Front Immunol. 2024, 15:1429009. 10.3389\/fimmu.2024.1429009","journal-title":"Front Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/path.4887","article-title":"IL-1\u03b2 induces thymic stromal lymphopoietin and an atopic dermatitis-like phenotype in reconstructed healthy human epidermis","volume":"242","author":"Bernard M","year":"2017","unstructured":"Bernard M, Carrasco C, Laoubi L, et al.. IL-1\u03b2 induces thymic stromal lymphopoietin and an atopic dermatitis-like phenotype in reconstructed healthy human epidermis. J Pathol. 2017, 242:234-45. 10.1002\/path.4887","journal-title":"J Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2023.2875","article-title":"Risk of inflammatory bowel disease in patients with atopic dermatitis","volume":"159","author":"Chiesa Fuxench ZC","year":"2023","unstructured":"Chiesa Fuxench ZC, Wan J, Wang S, Syed MN, Shin DB, Abuabara K, Gelfand JM. Risk of inflammatory bowel disease in patients with atopic dermatitis. JAMA Dermatol. 2023, 159:1085-92. 10.1001\/jamadermatol.2023.2875","journal-title":"JAMA Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2022.03.013","article-title":"T helper 2 IL-4\/IL-13 dual blockade with dupilumab is linked to some emergent T helper 17-type diseases, including seronegative arthritis and enthesitis\/enthesopathy, but not to humoral autoimmune diseases","volume":"142","author":"Bridgewood C","year":"2022","unstructured":"Bridgewood C, Wittmann M, Macleod T, et al.. T helper 2 IL-4\/IL-13 dual blockade with dupilumab is linked to some emergent T helper 17-type diseases, including seronegative arthritis and enthesitis\/enthesopathy, but not to humoral autoimmune diseases. J Invest Dermatol. 2022, 142:2660-7. 10.1016\/j.jid.2022.03.013","journal-title":"J Invest Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15493","article-title":"Efficacy and safety of ustekinumab in Japanese patients with severe atopic dermatitis: a randomized, double-blind, placebo-controlled, phase II study","volume":"177","author":"Saeki H","year":"2017","unstructured":"Saeki H, Kabashima K, Tokura Y, et al.. Efficacy and safety of ustekinumab in Japanese patients with severe atopic dermatitis: a randomized, double-blind, placebo-controlled, phase II study. Br J Dermatol. 2017, 177:419-27. 10.1111\/bjd.15493","journal-title":"Br J Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2021.1914315","article-title":"Effectiveness of ustekinumab in patients with atopic dermatitis: analysis of real-world evidence","volume":"33","author":"Husein-ElAhmed H","year":"2022","unstructured":"Husein-ElAhmed H, Steinhoff M. Effectiveness of ustekinumab in patients with atopic dermatitis: analysis of real-world evidence. J Dermatolog Treat. 2022, 33:1838-43. 10.1080\/09546634.2021.1914315","journal-title":"J Dermatolog Treat"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-024-09004-3","article-title":"Neutrophils in atopic dermatitis","volume":"67","author":"Chiang CC","year":"2024","unstructured":"Chiang CC, Cheng WJ, Dela Cruz JR, Raviraj T, Wu NL, Korinek M, Hwang TL. Neutrophils in atopic dermatitis. Clin Rev Allergy Immunol. 2024, 67:21-39. 10.1007\/s12016-024-09004-3","journal-title":"Clin Rev Allergy Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/483204-atopic-dermatitis-during-ustekinumab-therapy-in-a-patient-with-ulcerative-colitis-a-case-report-and-review-of-targeted-therapies-in-coexisting-diseases","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:14:17Z","timestamp":1778800457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/483204-atopic-dermatitis-during-ustekinumab-therapy-in-a-patient-with-ulcerative-colitis-a-case-report-and-review-of-targeted-therapies-in-coexisting-diseases"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.108859","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,14]]}}}